Your browser doesn't support javascript.
loading
Prospective, randomized trial to evaluate efficacy of a thrombin-based hemostatic agent in total knee arthroplasty.
Suarez, Juan C; Slotkin, Eric M; Alvarez, Andres M; Szubski, Caleb R; Barsoum, Wael K; Patel, Preetesh D.
Afiliación
  • Suarez JC; Cleveland Clinic Florida, Department of Orthopedic Surgery, 2950 Cleveland, Clinic Blvd, Weston, FL 33331.
  • Slotkin EM; Cleveland Clinic Florida, Department of Orthopedic Surgery, 2950 Cleveland, Clinic Blvd, Weston, FL 33331.
  • Alvarez AM; Cleveland Clinic Florida, Department of Orthopedic Surgery, 2950 Cleveland, Clinic Blvd, Weston, FL 33331.
  • Szubski CR; Cleveland Clinic, Department of Orthopedic Surgery, 9500 Euclid Avenue, Cleveland, OH 44195.
  • Barsoum WK; Cleveland Clinic, Department of Orthopedic Surgery, 9500 Euclid Avenue, Cleveland, OH 44195.
  • Patel PD; Cleveland Clinic Florida, Department of Orthopedic Surgery, 2950 Cleveland, Clinic Blvd, Weston, FL 33331.
J Arthroplasty ; 29(10): 1950-5, 2014 Oct.
Article en En | MEDLINE | ID: mdl-25015756
Total knee arthroplasty (TKA) can be associated with substantial blood loss, leading to increased morbidity and transfusion rates. The study objective was to evaluate routine use of a thrombin-based topical hemostatic matrix in reducing blood loss and transfusion requirements in primary TKA. 108 patients were enrolled in a prospective, randomized, single-center trial. Patients receiving the hemostatic agent demonstrated a lower mean calculated blood loss (1325.2±464.8mL vs. control, 1509.3±432.8mL; P=0.02), drain output (415.6±202.0mL vs. control, 579.9±306.7mL; P=0.008), and length of stay (3.3±0.8days vs. control, 3.7±1.1days; P=0.03), without a statistically significant difference in mean hemoglobin loss or transfusion requirements. The clinical utility of this hemostatic agent to reduce transfusions after uncomplicated, primary TKA continues to remain unclear.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemostáticos / Trombina / Pérdida de Sangre Quirúrgica / Hemorragia Posoperatoria / Artroplastia de Reemplazo de Rodilla / Esponja de Gelatina Absorbible Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Arthroplasty Asunto de la revista: ORTOPEDIA Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemostáticos / Trombina / Pérdida de Sangre Quirúrgica / Hemorragia Posoperatoria / Artroplastia de Reemplazo de Rodilla / Esponja de Gelatina Absorbible Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Arthroplasty Asunto de la revista: ORTOPEDIA Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos